Growth Metrics

Chemomab Therapeutics (CMMB) Exchange Rate Effect (2018 - 2019)

Chemomab Therapeutics posted quarterly Exchange Rate Effect of $25000.0 for Q3 2019, up 125.0% year-on-year from $11111.1 in Q3 2018, and down 83.55% on a QoQ basis from $152000.0 in Q4 2018.

Chemomab Therapeutics (CMMB) has 2 years of Exchange Rate Effect data on file, last reported at $25000.0 in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.60 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -2.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -40.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -900,000.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -7.06 Mn
10 Chemomab Therapeutics 959.23 Mn 948.86 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2019 25,000.00
Sep 30, 2019 25,000.00
Dec 31, 2018 152,000.00
Dec 31, 2018 152,000.00
Sep 30, 2018 -100,000.00
Sep 30, 2018 -100,000.00